111 related articles for article (PubMed ID: 28787396)
1. Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice.
Harris J; Herrero-Garcia E; Russo A; Kajdacsy-Balla A; O'Bryan JP; Chiu B
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e413-e418. PubMed ID: 28787396
[TBL] [Abstract][Full Text] [Related]
2. Intersectin 1 is required for neuroblastoma tumorigenesis.
Russo A; O'Bryan JP
Oncogene; 2012 Nov; 31(46):4828-34. PubMed ID: 22266851
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.
Russo A; Okur MN; Bosland M; O'Bryan JP
Cancer Lett; 2015 Apr; 359(2):262-8. PubMed ID: 25622909
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Wang H; Sun R; Chi Z; Li S; Hao L
Mol Cell Biochem; 2017 Sep; 433(1-2):1-12. PubMed ID: 28382490
[TBL] [Abstract][Full Text] [Related]
5. Analyses of Tumor Burden In Vivo and Metastasis Ex Vivo Using Luciferase-Expressing Cancer Cells in an Orthotopic Mouse Model of Neuroblastoma.
Byrne FL; McCarroll JA; Kavallaris M
Methods Mol Biol; 2016; 1372():61-77. PubMed ID: 26530915
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.
Daudigeos-Dubus E; LE Dret L; Rouffiac V; Bawa O; Leguerney I; Opolon P; Vassal G; Geoerger B
In Vivo; 2014; 28(4):425-34. PubMed ID: 24982206
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
Singh A; Rokes C; Gireud M; Fletcher S; Baumgartner J; Fuller G; Stewart J; Zage P; Gopalakrishnan V
Cancer; 2011 Nov; 117(22):5189-202. PubMed ID: 21523764
[TBL] [Abstract][Full Text] [Related]
9. Development of a Simple and Reproducible Cell-derived Orthotopic Xenograft Murine Model for Neuroblastoma.
Doyle K; Hassan AE; Sutter M; Rodriguez M; Kumar P; Brown E
In Vivo; 2024; 38(2):531-538. PubMed ID: 38418146
[TBL] [Abstract][Full Text] [Related]
10. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma.
Ghaghada KB; Starosolski ZA; Lakoma A; Kaffes C; Agarwal S; Athreya KK; Shohet J; Kim E; Annapragada A
PLoS One; 2016; 11(11):e0165877. PubMed ID: 27861510
[TBL] [Abstract][Full Text] [Related]
12. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
13. shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.
Wang H; Sun R; Gu M; Li S; Zhang B; Chi Z; Hao L
PLoS One; 2015; 10(5):e0127224. PubMed ID: 25993060
[TBL] [Abstract][Full Text] [Related]
14. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo.
Zhao J; Wei XL; Jia YS; Zheng JQ
Eur J Pharmacol; 2008 Jan; 579(1-3):50-7. PubMed ID: 17976575
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells accelerated growth and metastasis of neuroblastoma and preferentially homed towards both primary and metastatic loci in orthotopic neuroblastoma model.
Yu JL; Chan S; Fung MK; Chan GC
BMC Cancer; 2021 Apr; 21(1):393. PubMed ID: 33838662
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.
Mandriota SJ; Valentijn LJ; Lesne L; Betts DR; Marino D; Boudal-Khoshbeen M; London WB; Rougemont AL; Attiyeh EF; Maris JM; Hogarty MD; Koster J; Molenaar JJ; Versteeg R; Ansari M; Gumy-Pause F
Oncotarget; 2015 Jul; 6(21):18558-76. PubMed ID: 26053094
[TBL] [Abstract][Full Text] [Related]
17. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ
Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990
[TBL] [Abstract][Full Text] [Related]
18. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
[TBL] [Abstract][Full Text] [Related]
19. Stable knockdown of MYCN by lentivirus-based RNAi inhibits human neuroblastoma cells growth in vitro and in vivo.
Jiang R; Xue S; Jin Z
Biochem Biophys Res Commun; 2011 Jul; 410(2):364-70. PubMed ID: 21683062
[TBL] [Abstract][Full Text] [Related]
20. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
